{
    "nctId": "NCT05100277",
    "briefTitle": "Impact of Oncotype DX\u00ae on Treatment Recommendation and Its Economic Evaluation Under the Brazilian Society Perspective",
    "officialTitle": "Impact of Oncotype DX\u00ae on Treatment Recommendation of for Early-stage Hormone Receptor-positive Breast Cancer and Its Economic Evaluation Under the Brazilian Society Perspective",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Adjuvant Treatment",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 155,
    "primaryOutcomeMeasure": "The proportion of patients whose choice of treatment is changed as a result of Oncotype Test Low risk",
    "eligibilityCriteria": "Inclusion Criteria:\n\nWomen \u2265 18 years Early stage breast cancer, ER and/or PR positive with HER2 negative breast cancer.\n\nExclusion Criteria:\n\nMore than one operable primary breast tumor; Multifocal or multicentric tumors; 4 or more lymph node involvement; Metastatic breast cancer; Previous history of breast cancer; Invasive tumor \\<2 mm ; Performance status \\> 2 and / or other clinical factors that would make the patient a non-viable candidate for adjuvant chemotherapy; Previous hormonal or chemotherapy treatment; Current medical condition that would interfere with their ability to consent (psychiatric illness, for example)",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}